About 600 results
Open links in new tab
  1. CEPI

    Dec 18, 2025 · CEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership working to accelerate the development of vaccines and other biologic countermeasures …

  2. About CEPI

    CEPI was launched after the global response to the 2014-2016 West Africa Ebola epidemic fell tragically short and there was a consensus that a coordinated, international, and …

  3. CEPI 2.0 and the 100 Days Mission

    CEPI’s 2022-2026 strategy, known as CEPI 2.0, is helping to Prepare, Transform, and Connect the world so that it can respond to the next Disease X by accelerating the development of …

  4. Calls for Proposals - CEPI

    We’ll also provide you with some guidance and recommendations on your project and a potential application to one or more of CEPI’s Calls. We are particularly interested in hearing from …

  5. Our portfolio - CEPI

    Our interactive portfolio provides information on each of the vaccine candidates that CEPI has invested in as well as our Centralised Lab Network, Preclinical Models and Vaccine …

  6. News - CEPI

    Jan 5, 2026 · Keep up-to-date on the latest announcements and updates from CEPI and our global partners.

  7. Careers - CEPI

    We foster a learning-centred work culture. Our development approach is to enable everyone at CEPI to get better every day. The nature of our work also enables us to learn through …

  8. Partner with us - CEPI

    The innovations that CEPI supports not only protect some of the most vulnerable people in the world but will also help to prevent future pandemics. Funding committed to CEPI by our …

  9. Why we exist - CEPI

    Jan 7, 2026 · CEPI was launched at Davos in 2017 as the result of a consensus that a coordinated, international, and intergovernmental plan was needed to develop and deploy new …

  10. COVID-19 - CEPI

    On January 23, when just 581 cases of the virus had been confirmed worldwide, CEPI launched its first three programmes to accelerate vaccine development against this novel pathogen.